Dynamic Docking of Conformationally Constrained Macrocycles: Methods and Applications.
暂无分享,去创建一个
[1] Stephen F Martin,et al. Thermodynamic and structural effects of conformational constraints in protein-ligand interactions. Entropic paradoxy associated with ligand preorganization. , 2009, Journal of the American Chemical Society.
[2] W. Jiao,et al. New Tripeptide‐Based Macrocyclic Calpain Inhibitors Formed by N‐Alkylation of Histidine , 2012, Chemistry & biodiversity.
[3] R. Bazzo,et al. NMR Analysis of Molecular Flexibility in Solution: A New Method for the Study of Complex Distributions of Rapidly Exchanging Conformations. Application to a 13-Residue Peptide with an 8-Residue Loop , 1995 .
[4] Glen E. Kellogg,et al. Hydrophobicity: is LogPo/w more than the sum of its parts? , 2000 .
[5] N. Fujii,et al. Molecular modeling study of cyclic pentapeptide CXCR4 antagonists: new insight into CXCR4-FC131 interactions. , 2012, Bioorganic & medicinal chemistry letters.
[6] Igor V. Filippov,et al. PDB Ligand Conformational Energies Calculated Quantum-Mechanically , 2012, J. Chem. Inf. Model..
[7] Matthew P. Jacobson,et al. A Molecular Mechanics Approach to Modeling Protein-Ligand Interactions: Relative Binding Affinities in Congeneric Series , 2011, J. Chem. Inf. Model..
[8] F. D. Leeuw,et al. The relationship between proton-proton NMR coupling constants and substituent electronegativities—I : An empirical generalization of the karplus equation , 1980 .
[9] Jesús Jiménez-Barbero,et al. The bound conformation of microtubule-stabilizing agents: NMR insights into the bioactive 3D structure of discodermolide and dictyostatin. , 2008, Chemistry.
[10] Wolfgang Brandt,et al. Chemoinformatic analysis of biologically active macrocycles. , 2010, Current topics in medicinal chemistry.
[11] Ian Collins,et al. Macrocycles in new drug discovery. , 2012, Future medicinal chemistry.
[12] J. Trent,et al. Stereoselective synthesis of [L-Arg-L/D-3-(2-naphthyl)alanine]-type (E)-alkene dipeptide isosteres and its application to the synthesis and biological evaluation of pseudopeptide analogues of the CXCR4 antagonist FC131. , 2005, Journal of medicinal chemistry.
[13] C. Curti,et al. Targeting αvβ3 Integrin: Design and Applications of Mono- and Multifunctional RGD-Based Peptides and Semipeptides , 2010 .
[14] A. Joachimiak,et al. CRYSTAL STRUCTURE OF THE EXTRACELLULAR SEGMENT OF INTEGRIN ALPHA VBETA3 BOUND TO MN2 , 2002 .
[15] Elizabeth Yuriev,et al. Challenges and advances in computational docking: 2009 in review , 2011, Journal of molecular recognition : JMR.
[16] Stephen P. Hale,et al. The exploration of macrocycles for drug discovery — an underexploited structural class , 2008, Nature Reviews Drug Discovery.
[17] L. Johnson,et al. Structure-based design of cyclin-dependent kinase inhibitors. , 2002, Pharmacology & therapeutics.
[18] C. E. Peishoff,et al. A critical assessment of docking programs and scoring functions. , 2006, Journal of medicinal chemistry.
[19] G. Bifulco,et al. Synthesis of new mono and bis amides projected as potential histone deacetylase (HDAC) inhibitors , 2010 .
[20] W. C. Still,et al. The multiple minimum problem in molecular modeling. Tree searching internal coordinate conformational space , 1988 .
[21] H. Kolmar,et al. Between two worlds: a comparative study on in vitro and in silico inhibition of trypsin and matriptase by redox-stable SFTI-1 variants at near physiological pH. , 2012, Organic & biomolecular chemistry.
[22] M. Saviano,et al. Solid state and solution conformation of [Ala7]-phalloidin: a synthetic phallotoxin analogue. , 2001, Chemistry.
[23] Leslie A Kuhn,et al. Modeling correlated main‐chain motions in proteins for flexible molecular recognition , 2004, Proteins.
[24] Yiwu Yao,et al. Biological evaluation of new largazole analogues: alteration of macrocyclic scaffold with click chemistry. , 2013, ACS medicinal chemistry letters.
[25] M. Katharine Holloway,et al. Molecular modeling based approach to potent P2-P4 macrocyclic inhibitors of hepatitis C NS3/4A protease. , 2008, Journal of the American Chemical Society.
[26] Siegfried S. F. Leung,et al. Cell-permeable cyclic peptides from synthetic libraries inspired by natural products. , 2015, Journal of the American Chemical Society.
[27] S. Ōmura,et al. Molecular modeling of human acidic mammalian chitinase in complex with the natural-product cyclopentapeptide chitinase inhibitor argifin. , 2009, Bioorganic & medicinal chemistry.
[28] M. Karplus,et al. The HSP90 binding mode of a radicicol-like E-oxime determined by docking, binding free energy estimations, and NMR 15N chemical shifts. , 2009, Biophysical chemistry.
[29] F. Ding,et al. Discrete molecular dynamics , 2012 .
[30] L. Gentilucci,et al. Antiangiogenic effect of dual/selective alpha(5)beta(1)/alpha(v)beta(3) integrin antagonists designed on partially modified retro-inverso cyclotetrapeptide mimetics. , 2009, Journal of medicinal chemistry.
[31] D. Fairlie,et al. Macrocyclic Peptidomimetics Forcing Peptides into Bioactive Conformations , 1995, Current Medicinal Chemistry.
[32] Matthew P Jacobson,et al. Conformational flexibility, internal hydrogen bonding, and passive membrane permeability: successful in silico prediction of the relative permeabilities of cyclic peptides. , 2006, Journal of the American Chemical Society.
[33] R. Lokey,et al. Form and function in cyclic peptide natural products: a pharmacokinetic perspective. , 2013, Current topics in medicinal chemistry.
[34] J. Snyder,et al. A Test of the Single-Conformation Hypothesis in the Analysis of NMR Data for Small Polar Molecules: A Force Field Comparison , 1999 .
[35] M. James,et al. Lowering the entropic barrier for binding conformationally flexible inhibitors to enzymes. , 1998, Biochemistry.
[36] Laura Belvisi,et al. Determination of the binding epitope of RGD-peptidomimetics to αvβ3 and α(IIb)β3 integrin-rich intact cells by NMR and computational studies. , 2013, Organic & biomolecular chemistry.
[37] M. Civera,et al. Cyclic isoDGR peptidomimetics as low-nanomolar αvβ3 integrin ligands. , 2013, Chemistry.
[38] Shuichi Hirono,et al. Camdas: An automated conformational analysis system using molecular dynamics , 1997, J. Comput. Aided Mol. Des..
[39] Nicolas Foloppe,et al. Tackling the conformational sampling of larger flexible compounds and macrocycles in pharmacology and drug discovery. , 2013, Bioorganic & medicinal chemistry.
[40] M. Saraste,et al. FEBS Lett , 2000 .
[41] A. Pupi,et al. Morpholine-based RGD-cyclopentapeptides as alphavbeta3/alphavbeta5 integrin ligands: role of configuration towards receptor binding affinity. , 2009, Bioorganic & medicinal chemistry.
[42] C. Heinis,et al. Drug discovery: tools and rules for macrocycles. , 2014, Nature chemical biology.
[43] Robert C. Liddington,et al. Faculty Opinions recommendation of Crystal structure of the extracellular segment of integrin alpha Vbeta3 in complex with an Arg-Gly-Asp ligand. , 2002 .
[44] D. Case,et al. Rescoring docking hit lists for model cavity sites: predictions and experimental testing. , 2008, Journal of molecular biology.
[45] J. Janin. Assessing predictions of protein–protein interaction: The CAPRI experiment , 2005, Protein science : a publication of the Protein Society.
[46] Hongxing Lei,et al. Improved sampling methods for molecular simulation. , 2007, Current opinion in structural biology.
[47] Xiaoming Xu,et al. The Assembly-Inducing Laulimalide/Peloruside A Binding Site on Tubulin: Molecular Modeling and Biochemical Studies with [3H]Peloruside A , 2010, J. Chem. Inf. Model..
[48] Ross C. Walker,et al. An overview of the Amber biomolecular simulation package , 2013 .
[49] D. Abraham,et al. Hydrophobicity: is LogP(o/w) more than the sum of its parts? , 2000, European journal of medicinal chemistry.
[50] Vincent Zoete,et al. Design, synthesis, and biological evaluation of HSP90 inhibitors based on conformational analysis of radicicol and its analogues. , 2005, Journal of the American Chemical Society.
[51] Raymond E. Moellering,et al. Direct inhibition of the NOTCH transcription factor complex , 2009, Nature.
[52] Xiaoqin Zou,et al. Advances and Challenges in Protein-Ligand Docking , 2010, International journal of molecular sciences.
[53] Woody Sherman,et al. ConfGen: A Conformational Search Method for Efficient Generation of Bioactive Conformers , 2010, J. Chem. Inf. Model..
[54] Jianpeng Ma,et al. CHARMM: The biomolecular simulation program , 2009, J. Comput. Chem..
[55] Roy Bickerstaffe,et al. Molecular modeling: a search for a calpain inhibitor as a new treatment for cataractogenesis. , 2011, Journal of medicinal chemistry.
[56] Feng,et al. Synthesis of a New , 2001 .
[57] Andrei K. Yudin,et al. Macrocycles: lessons from the distant past, recent developments, and future directions , 2014, Chemical science.
[58] M. Karplus,et al. Asymmetric synthesis of pochonin E and F, revision of their proposed structure, and their conversion to potent Hsp90 inhibitors. , 2012, Chemistry.
[59] M. Karplus. Contact Electron‐Spin Coupling of Nuclear Magnetic Moments , 1959 .
[60] M. Rosenkilde,et al. Determination of the binding mode for the cyclopentapeptide CXCR4 antagonist FC131 using a dual approach of ligand modifications and receptor mutagenesis , 2014, British journal of pharmacology.
[61] J. M. Ribeiro,et al. Hydrolysis of the phosphoanhydride linkage of cyclic ADP‐ribose by the Mn2+‐dependent ADP‐ribose/CDP‐alcohol pyrophosphatase , 2009, FEBS letters.
[62] G. Klebe,et al. Development of new cyclic plasmin inhibitors with excellent potency and selectivity. , 2013, Journal of medicinal chemistry.
[63] G. Dive,et al. Unprecedented inhibition of resistant penicillin binding proteins by bis-2-oxoazetidinyl macrocycles , 2012 .
[64] Paul Labute,et al. LowModeMD - Implicit Low-Mode Velocity Filtering Applied to Conformational Search of Macrocycles and Protein Loops , 2010, J. Chem. Inf. Model..
[65] Jonas Boström,et al. Conformational energy penalties of protein-bound ligands , 1998, J. Comput. Aided Mol. Des..
[66] H. Scheraga,et al. Energy parameters in polypeptides. 9. Updating of geometrical parameters, nonbonded interactions, and hydrogen bond interactions for the naturally occurring amino acids , 1983 .
[67] Nir London,et al. Sub‐angstrom modeling of complexes between flexible peptides and globular proteins , 2010, Proteins.
[68] Laura Belvisi,et al. Cyclic RGD peptidomimetics containing bifunctional diketopiperazine scaffolds as new potent integrin ligands. , 2009, Chemistry.
[69] G. R. Famini,et al. A computational study of solvent effects on the conformation of dopamine , 1992 .
[70] A. Spitaleri,et al. Use of metadynamics in the design of isoDGR-based αvβ3 antagonists to fine-tune the conformational ensemble. , 2011, Angewandte Chemie.
[71] Edward W. Lowe,et al. Computational Methods in Drug Discovery , 2014, Pharmacological Reviews.
[72] Dianqing Sun,et al. Macrocyclic Drugs and Synthetic Methodologies toward Macrocycles , 2013, Molecules.
[73] David C Schriemer,et al. Discovery and characterization of the laulimalide-microtubule binding mode by mass shift perturbation mapping. , 2010, Chemistry & biology.
[74] S. Renner,et al. Total synthesis of chondramide C and its binding mode to F-actin. , 2008, Angewandte Chemie.
[75] Kevin M. D'Auria,et al. Structural and dynamic determinants of protein-peptide recognition. , 2011, Structure.
[76] S. Renner,et al. Synthesis and Structure–Activity Correlation of a Brunsvicamide‐Inspired Cyclopeptide Collection , 2009, Chembiochem : a European journal of chemical biology.
[77] Amos B. Smith,et al. Interactions of Halichondrin B and Eribulin with Tubulin , 2011, J. Chem. Inf. Model..
[78] A. Abell,et al. Molecular modeling, synthesis, and biological evaluation of macrocyclic calpain inhibitors. , 2009, Angewandte Chemie.
[79] Leslie A Kuhn,et al. Protein unfolding: Rigidity lost , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[80] J. Trent,et al. Development of a linear type of low molecular weight CXCR4 antagonists based on T140 analogs. , 2006, Organic & biomolecular chemistry.
[81] É. Marsault,et al. Macrocycles are great cycles: applications, opportunities, and challenges of synthetic macrocycles in drug discovery. , 2011, Journal of medicinal chemistry.
[82] H. Morita,et al. Conformational Analysis of a Marine Antineoplastic Macrolide, Bryostatin 10. , 1996 .
[83] J. Wood,et al. Discovery of the macrocycle (9E)-15-(2-(pyrrolidin-1-yl)ethoxy)-7,12,25-trioxa-19,21,24-triaza-tetracyclo[18.3.1.1(2,5).1(14,18)]hexacosa-1(24),2,4,9,14(26),15,17,20,22-nonaene (SB1578), a potent inhibitor of janus kinase 2/fms-like tyrosine kinase-3 (JAK2/FLT3) for the treatment of rheumatoid arthr , 2012, Journal of medicinal chemistry.
[84] Elizabeth Yuriev,et al. Latest developments in molecular docking: 2010–2011 in review , 2013, Journal of molecular recognition : JMR.
[85] Anders Poulsen,et al. Structure-based design of oxygen-linked macrocyclic kinase inhibitors: discovery of SB1518 and SB1578, potent inhibitors of Janus kinase 2 (JAK2) and Fms-like tyrosine kinase-3 (FLT3) , 2012, Journal of Computer-Aided Molecular Design.
[86] Eric Sun,et al. Structure-based design of Aurora A & B inhibitors , 2008, J. Comput. Aided Mol. Des..
[87] J. Wood,et al. Discovery of Kinase Spectrum Selective Macrocycle , 2011 .
[88] J. Wood,et al. Discovery of kinase spectrum selective macrocycle (16E)-14-methyl-20-oxa-5,7,14,26-tetraazatetracyclo[19.3.1.1(2,6).1(8,12)]heptacosa-1(25),2(26),3,5,8(27),9,11,16,21,23-decaene (SB1317/TG02), a potent inhibitor of cyclin dependent kinases (CDKs), Janus kinase 2 (JAK2), and fms-like tyrosine kinase- , 2012, Journal of medicinal chemistry.
[89] A. Laio,et al. Metadynamics: a method to simulate rare events and reconstruct the free energy in biophysics, chemistry and material science , 2008 .
[90] Matthew P Jacobson,et al. Testing the conformational hypothesis of passive membrane permeability using synthetic cyclic peptide diastereomers. , 2006, Journal of the American Chemical Society.
[91] Richard W Roberts,et al. mRNA display: ligand discovery, interaction analysis and beyond. , 2003, Trends in biochemical sciences.
[92] Anders Poulsen,et al. Discovery of the macrocycle 11-(2-pyrrolidin-1-yl-ethoxy)-14,19-dioxa-5,7,26-triaza-tetracyclo[19.3.1.1(2,6).1(8,12)]heptacosa-1(25),2(26),3,5,8,10,12(27),16,21,23-decaene (SB1518), a potent Janus kinase 2/fms-like tyrosine kinase-3 (JAK2/FLT3) inhibitor for the treatment of myelofibrosis and lympho , 2011, Journal of medicinal chemistry.
[93] Dima Kozakov,et al. How Proteins Bind Macrocycles , 2014, Nature chemical biology.
[95] T. Kuzuhara,et al. Anti-Influenza Activity of Marchantins, Macrocyclic Bisbibenzyls Contained in Liverworts , 2011, PloS one.
[96] J. Snyder,et al. Relationship among ligand conformations in solution, in the solid state, and at the Hsp90 binding site: geldanamycin and radicicol. , 2007, Journal of the American Chemical Society.
[97] Horst Kessler,et al. Receptor-bound conformation of cilengitide better represented by its solution-state structure than the solid-state structure. , 2014, Chemistry.
[98] Christoph A. Sotriffer,et al. Virtual screening : principles, challenges, and practical guidelines , 2011 .
[99] Peter M. Kasson,et al. GROMACS 4.5: a high-throughput and highly parallel open source molecular simulation toolkit , 2013, Bioinform..
[100] W. Wooster,et al. Crystal structure of , 2005 .
[101] M. Teulade‐Fichou,et al. Macrocyclic DNA-mismatch-binding ligands: structural determinants of selectivity. , 2010, Chemistry.
[102] P. Dumy,et al. Double threading through DNA: NMR structural study of a bis-naphthalene macrocycle bound to a thymine–thymine mismatch , 2012, Nucleic acids research.
[103] H. Morita,et al. Conformational analysis of a marine antineoplastic macrolide, bryostatin 10☆ , 1996 .
[104] F. A. Neugebauer,et al. Electrochemical oxidation and structural changes of 5,6-dihydrobenzo[c]cinnolines , 1996 .
[105] Nir London,et al. Can self‐inhibitory peptides be derived from the interfaces of globular protein–protein interactions? , 2010, Proteins.
[106] Michael W Deem,et al. Parallel tempering: theory, applications, and new perspectives. , 2005, Physical chemistry chemical physics : PCCP.
[107] Martin Lepšík,et al. Assessing the accuracy and performance of implicit solvent models for drug molecules: conformational ensemble approaches. , 2013, The journal of physical chemistry. B.
[108] Christopher R. Corbeil,et al. Towards the development of universal, fast and highly accurate docking/scoring methods: a long way to go , 2008, British journal of pharmacology.
[109] G. Marshall,et al. A minimalistic 3D pharmacophore model for cyclopentapeptide CXCR4 antagonists , 2006, Biopolymers.
[110] A. Olson,et al. Rediocides A and G as Potential Antitoxins Against Cobra Venom , 2009, Chemistry & biodiversity.
[111] N. Sigal,et al. Cyclosporin A, FK-506, and Rapamycin: Pharmacologic Probes of Lymphocyte Signal Transduction , 1992 .
[112] A. Laio,et al. Escaping free-energy minima , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[113] New cyclic RGD peptides: synthesis, characterization, and theoretical activity towards αvβ3 integrin , 2014 .
[114] M. Rosenkilde,et al. Rational design of conformationally constrained cyclopentapeptide antagonists for C-x-C chemokine receptor 4 (CXCR4). , 2012, Journal of medicinal chemistry.
[115] M. Rudd,et al. Discovery of MK-5172, a Macrocyclic Hepatitis C Virus NS3/4a Protease Inhibitor. , 2012, ACS medicinal chemistry letters.
[116] T. Steinmetzer,et al. A new strategy for the development of highly potent and selective plasmin inhibitors. , 2012, Journal of medicinal chemistry.
[117] M. Steinmetz,et al. Structural basis of microtubule stabilization by laulimalide and peloruside A. , 2014, Angewandte Chemie.
[118] Thilo Stehle,et al. Crystal Structure of the Extracellular Segment of Integrin αVβ3 in Complex with an Arg-Gly-Asp Ligand , 2002, Science.
[119] Brian J. Smith,et al. Stabilizing the pro-apoptotic BimBH3 helix (BimSAHB) does not necessarily enhance affinity or biological activity. , 2013, ACS chemical biology.
[120] P. Charifson,et al. Conformational analysis of drug-like molecules bound to proteins: an extensive study of ligand reorganization upon binding. , 2004, Journal of medicinal chemistry.
[121] G. Chang,et al. An internal-coordinate Monte Carlo method for searching conformational space , 1989 .
[122] S. Schreiber,et al. Synthesis and conformation-activity relationships of the peptide isosteres of FK228 and largazole. , 2009, Journal of the American Chemical Society.
[123] G. G. Stokes. "J." , 1890, The New Yale Book of Quotations.
[124] P. Blumberg,et al. Molecular modeling, total synthesis, and biological evaluations of C9-deoxy bryostatin 1. , 2010, Angewandte Chemie.
[125] Ming Lei,et al. Sampling protein conformations and pathways , 2004, J. Comput. Chem..
[126] T. Krahn,et al. Structure-function relation of efomycines, a family of small-molecule inhibitors of selectin functions. , 2006, The Journal of investigative dermatology.
[127] István Kolossváry,et al. Low Mode Search . An Efficient , Automated Computational Method for Conformational Analysis : Application to Cyclic and Acyclic Alkanes and Cyclic Peptides , 1997 .
[128] W. Setzer,et al. Cembrene Diterpenoids: Conformational Studies and Molecular Docking to Tubulin , 2010 .
[129] Charles L. Brooks,et al. Detailed analysis of grid‐based molecular docking: A case study of CDOCKER—A CHARMm‐based MD docking algorithm , 2003, J. Comput. Chem..
[130] A. Poulsen,et al. Structure-based design of nitrogen-linked macrocyclic kinase inhibitors leading to the clinical candidate SB1317/TG02, a potent inhibitor of cyclin dependant kinases (CDKs), Janus kinase 2 (JAK2), and Fms-like tyrosine kinase-3 (FLT3) , 2012, Journal of Molecular Modeling.
[131] Computer-aided rational molecular design of argifin-derivatives with increased inhibitory activity against chitinase B from Serratia marcescens. , 2009, Bioorganic & medicinal chemistry letters.
[132] R. Kroemer. Structure-based drug design: docking and scoring. , 2007, Current protein & peptide science.
[133] J. Tuszynski,et al. A unique mode of microtubule stabilization induced by peloruside A. , 2008, Journal of molecular biology.
[134] J M Thornton,et al. Multiple solution conformations of the integrin-binding cyclic pentapeptide cyclo(-Ser-D-Leu-Asp-Val-Pro-). Analysis of the (phi, psi) space available to cyclic pentapeptides. , 1996, European journal of biochemistry.
[135] Nikolay V. Dokholyan,et al. Identification and Rational Redesign of Peptide Ligands to CRIP1, A Novel Biomarker for Cancers , 2008, PLoS Comput. Biol..
[136] David R. Liu,et al. DNA-templated organic synthesis: nature's strategy for controlling chemical reactivity applied to synthetic molecules. , 2004, Angewandte Chemie.